306 related articles for article (PubMed ID: 25741163)
1. Meta-analysis: is combination of tetracycline and amoxicillin suitable for Helicobacter pylori infection?
Lv ZF; Wang FC; Zheng HL; Wang B; Xie Y; Zhou XJ; Lv NH
World J Gastroenterol; 2015 Feb; 21(8):2522-33. PubMed ID: 25741163
[TBL] [Abstract][Full Text] [Related]
2. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
Luther J; Higgins PD; Schoenfeld PS; Moayyedi P; Vakil N; Chey WD
Am J Gastroenterol; 2010 Jan; 105(1):65-73. PubMed ID: 19755966
[TBL] [Abstract][Full Text] [Related]
3. Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis.
Wang B; Lv ZF; Wang YH; Wang H; Liu XQ; Xie Y; Zhou XJ
World J Gastroenterol; 2014 Oct; 20(40):14973-85. PubMed ID: 25356059
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
5. Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Jul; 21(26):8132-9. PubMed ID: 26185386
[TBL] [Abstract][Full Text] [Related]
6. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
7. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.
Di Caro S; Fini L; Daoud Y; Grizzi F; Gasbarrini A; De Lorenzo A; Di Renzo L; McCartney S; Bloom S
World J Gastroenterol; 2012 Oct; 18(40):5669-78. PubMed ID: 23155306
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 May; 21(18):5568-74. PubMed ID: 25987781
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of the two tetracycline-containing sequential therapy regimens for the eradication of Helicobacter pylori: 5 days versus 14 days amoxicillin.
Cetinkaya ZA; Sezikli M; Güzelbulut F; Coşgun S; Düzgün S; Kurdaş OO
Helicobacter; 2010 Apr; 15(2):143-7. PubMed ID: 20402816
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta-analysis of RCTs.
Gao W; Zhu M; Yin Y; Zhang X; Wang L
Helicobacter; 2023 Dec; 28(6):e13022. PubMed ID: 37839018
[TBL] [Abstract][Full Text] [Related]
12. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey.
Sezgin O; Altintaş E; Nayir E; Uçbilek E
Helicobacter; 2007 Dec; 12(6):629-32. PubMed ID: 18001405
[TBL] [Abstract][Full Text] [Related]
13. Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.
Lin LC; Hsu TH; Huang KW; Tam KW
World J Gastroenterol; 2016 Jun; 22(23):5445-53. PubMed ID: 27340362
[TBL] [Abstract][Full Text] [Related]
14. Doxycycline in Eradication Therapy of Helicobacter pylori--a Systematic Review and Meta-Analysis.
Niv Y
Digestion; 2016; 93(2):167-73. PubMed ID: 26849820
[TBL] [Abstract][Full Text] [Related]
15. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of ecabet sodium as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis.
Wang Y; Wang B; Lv ZF; Yang Y; Wang F; Wang H; Chen S; Xie Y; Zhou X
Helicobacter; 2014 Oct; 19(5):372-81. PubMed ID: 24826809
[TBL] [Abstract][Full Text] [Related]
17. Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.
Liao XM; Nong GH; Chen MZ; Huang XP; Cong YY; Huang YY; Wu BH; Wei JQ
World J Gastroenterol; 2015 May; 21(20):6310-6. PubMed ID: 26034367
[TBL] [Abstract][Full Text] [Related]
18. Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.
Kang JM; Kim N; Lee DH; Park YS; Kim YR; Kim JS; Jung HC; Song IS
Helicobacter; 2007 Dec; 12(6):623-8. PubMed ID: 18001404
[TBL] [Abstract][Full Text] [Related]
19. The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.
Aktaş B; Başyiğit S; Yüksel O; Akkan T; Atbaşı ST; Uzman M; Yılmaz B; Şimşek G; Nazlıgül Y
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):769-75. PubMed ID: 25919773
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
